BioSpace News Archive

Dômes Pharma announces that it has finalized the acquisition of SentrX Animal Care, a US company based in Salt Lake City. SentrX develops and manufactures ophthalmology products based on its exclusive BioHAnce™ technology.

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the achievement of First-Patient-In for the company-sponsored Phase 2 clinical trial evaluating darovasertib as neoadjuvant and adjuvant therapy in primary uveal melanoma patients.

AbTherx, a privately held biotech company with innovative technologies that enable and accelerate antibody discovery, announced the appointment of Gavin Thurston, PhD, as a scientific advisor.

ChemDiv Inc, a global leader in drug discovery and drug development solutions, shares the progress in the development of its cutting-edge biology facility at Biocant Park, Cantanhede, Portugal.

Nevro Corp. today announced the publication of 24-month data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT), the largest RCT to evaluate spinal cord stimulation (SCS) to treat PDN, in Diabetes Research and Clinical Practice.

Oncoclínicas Group generated record earnings in the second quarter of 2023, R$309 million and a net profit of R$35 million.

FesariusTherapeutics, Inc. today announced they have been awarded an $800,000 SBIR CRP grant to advance the development of their novel DermiSphere™ dermal regenerative template to treat full thickness skin loss.

bluebird bio, Inc. (Nasdaq: BLUE) today announced that the U.S. Food and Drug Administration (FDA) has communicated that an advisory committee meeting will not be scheduled for lovotibeglogene autotemcel (lovo-cel).

Silence Therapeutics plc today reported its financial results for the second quarter ended June 30, 2023 and reviewed recent business highlights.

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal 2023 results.